• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    RadNet Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    1/9/26 4:15:25 PM ET
    $RDNT
    Medical Specialities
    Health Care
    Get the next $RDNT alert in real time by email
    RadNet, Inc. 8-K
    false 0000790526 0000790526 2026-01-06 2026-01-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported) January 6, 2026

     

    RadNet, Inc.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-33307   13-3326724
    (State or other jurisdiction
    of incorporation)
      (Commission File Number)   (IRS Employer Identification No.)

     

    1510 Cotner Avenue    
    Los Angeles, California   90025
    (Address of Principal Executive Offices)   (Zip Code)

      

    Registrant’s Telephone Number, Including Area Code: (310) 478-7808

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

    Trading Symbol(s) Name of each exchange on which registered
    Common Stock, $0.0001 par value RDNT NASDAQ

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

       

     

     

    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    Promotion of Executive Officers

     

    On January 7, 2026, RadNet, Inc. (the “Company”) announced the expansion of four executive leadership roles, and effective immediately, the promotion of certain officers, including (1) Stephen Forthuber from President and Chief Operating Officer, Eastern Operations to President and Chief Executive Officer, Eastern Operations, (2) Norman Hames from President and Chief Operating Officer, Western Operations to President and Chief Executive Officer, Western Operations, and (3) Mital Patel from Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer to Executive Vice President and Chief Operating Officer.

     

    The biographies of Mr. Forthuber, Mr. Hames and Mr. Patel are contained in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 28, 2025 under the heading “Executive Officers,” and such biographies are incorporated herein by reference. There are no arrangements or understandings between each of Mr. Forthuber, Mr. Hames and Mr. Patel and any other persons pursuant to which each of Mr. Forthuber, Mr. Hames and Mr. Patel was appointed as President and Chief Executive Officer, Eastern Operations, President and Chief Executive Officer, Western Operations, and Executive Vice President and Chief Operating Officer, respectively. Each of Mr. Forthuber, Mr. Hames and Mr. Patel does not have any family relationship with any director or executive officer of the Company or any person nominated or chosen by the Company to become a director or executive officer.

     

    In connection with the promotions of Mr. Forthuber as President and Chief Executive Officer, Eastern Operations, Mr. Hames as President and Chief Executive Officer, Western Operations, and Mr. Patel as Executive Vice President and Chief Operating Officer, and routine adjustments to annual base salary approved by the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) on January 6, 2026, the Company, through Radnet Management, Inc., a wholly-owned subsidiary of RadNet (“RMI”), intends to enter into amendments (the “Promoted Officer Amendments”) to the executive employment agreements originally entered into by and between RMI and each of Mr. Forthuber, Mr. Hames and Mr. Patel on September 1, 2022 (the “Promoted Officer Employment Agreements”) to revise each of their annual base salaries to $950,000, $950,000 and $925,000, respectively, effective January 1, 2026. 

     

    Other than each of their employment relationships with the Company as disclosed herein, and each of their compensation and benefits in connection with such employment relationship, there are no transactions in which each of Mr. Forthuber, Mr. Hames and Mr. Patel has an interest requiring disclosure under Item 404(a) of Regulation S-K.

     

    Amendments to Executive Employment Agreements

     

    On January 6, 2026, the Compensation Committee approved adjustments in annual base salary as set forth in the table below for members of the Company’s executive management team, including for Mark Stolper, the Company’s Executive Vice President and Chief Financial Officer and for the Company’s named executive officers–Mr. Forthuber, Mr. Hames and Cornelius Wesdorp, the Company’s President and Chief Executive Officer, Digital Health. The Company, through its subsidiaries, intends to enter into amendments to the executive employment agreements with the members of the Company’s executive management team to revise each of their annual base salaries, effective January 1, 2026 (together with the Promoted Officer Amendments, the “Amendments”).

     

     

     

     2 

     

     

    Name Title Annual Salary
    Mark D. Stolper Executive Vice President and $850,000
      Chief Financial Officer
         
    Stephen M. Forthuber President and $950,000
      Chief Executive Officer -  
      Eastern Operations  
         
    Norman R. Hames President and $950,000
      Chief Executive Officer -  
      Western Operations  
         
    Cornelis Wesdorp President and $850,000
      Chief Executive Officer -  
      Digital Health  

     

    Except for the change in annual base salary, all other provisions of the executive employment agreements remain in full force and effect.

     

    The foregoing descriptions of the Amendments do not purport to be complete and are qualified in their entirety by reference to the full text of the Amendments, copies of which will be filed with the Company's Annual Report on Form 10-K for the year ended December 31, 2025.

     

    Item 7.01. Regulation FD Disclosure.

     

    On January 7, 2026, the Company issued a press release announcing the promotion of Mr. Forthuber, Mr. Hames, Mr. Patel, and Dr. Greg Sorensen, M.D. to their respective positions. A copy of the press release is attached hereto as Exhibit 99.1. The information contained in Item 7.01 of this current report, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) The following exhibit is furnished herewith: 

     

    Exhibit No.   Description
         
    99.1   Press Release dated January 7, 2026
    104   Cover Page Interactive Date File - the cover page XBRL tags are embedded within the Inline XBRL document

     

     

     

     

     

     

     

     3 

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: January 9, 2026 RadNet, Inc.
       
         
      By: /s/ David J. Katz
      Name: David J. Katz
      Title: Executive Vice President, Chief Legal Officer and Corporate Secretary

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     4 

    Get the next $RDNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RDNT

    DatePrice TargetRatingAnalyst
    1/9/2026$92.00Overweight
    KeyBanc Capital Markets
    6/13/2025$69.00Buy
    B. Riley Securities
    3/5/2025$85.00 → $65.00Outperform → Strong Buy
    Raymond James
    9/6/2024$57.00 → $79.00Equal Weight → Overweight
    Barclays
    3/6/2024$48.00Equal Weight
    Barclays
    8/31/2023$40.00Buy
    Truist
    3/31/2023$30.00Market Outperform
    CJS Securities
    3/3/2023$30.00Mkt Perform → Outperform
    Raymond James
    More analyst ratings

    $RDNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KeyBanc Capital Markets initiated coverage on RadNet with a new price target

    KeyBanc Capital Markets initiated coverage of RadNet with a rating of Overweight and set a new price target of $92.00

    1/9/26 9:07:04 AM ET
    $RDNT
    Medical Specialities
    Health Care

    B. Riley Securities initiated coverage on RadNet with a new price target

    B. Riley Securities initiated coverage of RadNet with a rating of Buy and set a new price target of $69.00

    6/13/25 7:50:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet upgraded by Raymond James with a new price target

    Raymond James upgraded RadNet from Outperform to Strong Buy and set a new price target of $65.00 from $85.00 previously

    3/5/25 7:50:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Financial Officer Stolper Mark exercised 35,703 shares at a strike of $6.07, increasing direct ownership by 52% to 103,715 units (SEC Form 4)

    4 - RadNet, Inc. (0000790526) (Issuer)

    12/12/25 4:15:27 PM ET
    $RDNT
    Medical Specialities
    Health Care

    EVP and Chief Legal Officer Katz David Jeffrey exercised 3,396 shares at a strike of $29.44, increasing direct ownership by 5% to 71,577 units (SEC Form 4)

    4 - RadNet, Inc. (0000790526) (Issuer)

    12/12/25 4:15:08 PM ET
    $RDNT
    Medical Specialities
    Health Care

    Pres & COO-Eastern Operations Forthuber Stephen M sold $3,531,849 worth of shares (45,088 units at $78.33), decreasing direct ownership by 8% to 529,221 units (SEC Form 4)

    4 - RadNet, Inc. (0000790526) (Issuer)

    12/9/25 4:15:21 PM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    RadNet, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference January 14th, 2026

    LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, Mark Stolper, Executive Vice President and Chief Financial Officer, Dr. Gregory Sorensen, Executive Vice President and Chief Strategy Officer and Kees Wesdorp, President & CEO of RadNet Digital Health will be presenting at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 14, 2026 at 10:30 a.m. PST. A live webcast of RadNet's presentati

    1/9/26 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet Expands to Southwest Florida with Acquisition of Radiology Regional

    LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a global developer of digital health solutions, announced today that it has acquired Radiology Regional, a division of LucidHealth serving Southwest Florida. The expansion brings RadNet's proven operational efficiencies and leading imaging technologies to 13 locations across Naples, Cape Coral, Fort Myers, Port Charlotte and Sarasota. In the past half-century, Radiology Regional has provided a comprehensive multi-modality offering that includes MRI, CT, PET/CT, mammography, ultrasound, X-ray and other related proc

    1/7/26 6:15:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet Names Four Leaders to Expanded Executive Roles

    LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a premier global developer of digital health solutions, announced today the promotion of four senior leaders to expanded executive roles in recognition of their decades of operational excellence and strategic growth. Effective immediately, the executive leadership changes include: Stephen Forthuber, President and Chief Operating Officer, Eastern Operations, to President and Chief Executive Officer, Eastern Operations.Norman Hames, President and Chief Operating Officer, Western Operations, to President and Chief E

    1/7/26 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    SEC Filings

    View All

    RadNet Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - RadNet, Inc. (0000790526) (Filer)

    1/9/26 4:15:25 PM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - RadNet, Inc. (0000790526) (Filer)

    12/4/25 5:29:49 PM ET
    $RDNT
    Medical Specialities
    Health Care

    SEC Form 424B7 filed by RadNet Inc.

    424B7 - RadNet, Inc. (0000790526) (Filer)

    12/4/25 5:29:13 PM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Financials

    Live finance-specific insights

    View All

    RadNet Acquires CIMAR UK, Empowering DeepHealth to Accelerate AI-Powered Imaging, Reporting and Image-Based Screening

    LOS ANGELES and LONDON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT) ("RadNet"), a US leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, announced today the acquisition of CIMAR UK, a leading provider of cloud-native healthcare image management solutions. CIMAR will be integrated into DeepHealth, RadNet's wholly owned subsidiary and a global leader in AI-powered health informatics, to advance connected imaging-based care. "Imaging and diagnostics sit at the forefront of care, serving as the gateway to treatment and disease management," said Kees Wesdorp, CEO and President of RadNet's Digital Health division, DeepHealt

    11/11/25 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges

    Total Company Revenue increased 13.4% to $522.9 million in the third quarter of 2025 from $461.1 million in the third quarter of 2024; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 51.6% to $24.8 million in the third quarter of 2025 from $16.4 million in the third quarter of 2024Total Company Adjusted EBITDA(1) was $84.9 million in the third quarter of 2025 as compared with $73.7 million in the third quarter of 2024, an increase of 15.2%; Digital Health reportable segment Adjusted EBITDA(1) increased 6.9% to $3.5 million in the third quarter of 2025 from $3.2 million in the third quarter of 2024Total Company Adjusted EBITDA(1) margins increa

    11/9/25 4:10:00 PM ET
    $RDNT
    Medical Specialities
    Health Care

    RadNet, Inc. Announces Date of its Third Quarter 2025 Financial Results Conference Call

    LOS ANGELES, Oct. 20, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital health solutions, announced today that it will host a conference call to discuss its third quarter 2025 financial results on Monday, November 10, 2025 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). Investors are invited to listen to RadNet's conference call by dialing 844-826-3035. International callers can dial 412-317-5195. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1740003

    10/20/25 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by RadNet Inc.

    SC 13G/A - RadNet, Inc. (0000790526) (Subject)

    11/12/24 4:51:53 PM ET
    $RDNT
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by RadNet Inc.

    SC 13G/A - RadNet, Inc. (0000790526) (Subject)

    11/4/24 1:22:38 PM ET
    $RDNT
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by RadNet Inc.

    SC 13G/A - RadNet, Inc. (0000790526) (Subject)

    10/24/24 6:36:21 PM ET
    $RDNT
    Medical Specialities
    Health Care

    $RDNT
    Leadership Updates

    Live Leadership Updates

    View All

    The Oncology Institute Announces Addition of Board Member Mark Stolper

    CERRITOS, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced that Mark Stolper has joined the Board of Directors, effective January 2, 2026. Mr. Stolper brings significant public markets, financial and operational leadership experience to The Oncology Institute's board. Mr. Stolper serves as Executive Vice President and Chief Financial Officer of RadNet, Inc. (NASDAQ:RDNT), a position he has held since 2004. Mr. Stolper has also been a member of the Board of Directors of various publicly traded and privately held healthcare companies, including 21st Century Oncolog

    1/5/26 8:30:00 AM ET
    $RDNT
    $TOI
    Medical Specialities
    Health Care
    Medical/Nursing Services

    RadNet, Inc. Announces the Appointment of Kees Wesdorp as President and Chief Executive Officer of RadNet's Digital Health Division

    Former Chief Business Leader of Philips' multi-billion-dollar Precision Diagnosis division and member of Philips' Executive CommitteeEnd-to-end responsibility for Philip's CT, MR, dXR, Ultrasound and Diagnostic Informatics (radiology software) businessesProven track record of building and managing radiology software solutions, including significant experience with AI development and commercialization LOS ANGELES, Sept. 12, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers and digital health solutions, announced today the appo

    9/12/24 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care